Navigation Links
Bright Light Therapy via Ear Canals Improved Reaction Times of Top Athletes in a Placebo-Controlled Psycho-Motoric Study
Date:12/14/2011

HELSINKI, December 14, 2011 /PRNewswire/ --

A placebo controlled study involving top ice hockey players from the Finnish national league has shown motoric reaction times reduced by one fifth in players using the Valkee bright light headset. In the treatment group, the athletes were given 12 minutes of bright light via the ear canal each morning for three weeks. The study was conducted by the Department of Exercise and Medical Physiology at Verve Research, Finland.

Motoric reaction times describe how quickly we react to visual stimulus and convert these into actual movements. The Valkee bright light headset is a portable device that channels 8-12 minute doses of safe bright light directly to light-sensitive areas of the brain via the ear canal. Earlier in 2011, University of Oulu, Finland, presented two clinical trials using bright light via ear canals to treat seasonal affective disorder, and the presence of light-sensitive cells in the human brain.

Docent Mikko Tulppo, who led the study at the Department of Exercise and Medical Physiology at Verve Research, Finland, commented: "The placebo-controlled study showed a significant improvement in motoric reaction times of top athletes using bright light via the ear canal."  

Juuso Nissilä, chief scientist at Valkee, the inventor of the bright light headset, said: "The ice hockey players were all in prime cognitive and physical condition, and their reaction times were already extremely fast already before using the Valkee bright light headset. The fact that bright light via ear canals is proving to provide an additional edge is very promising for athletes and sports enthusiasts."

This placebo-controlled, phycho-motoric study of Valkee bright light via ear canal on national level ice hockey players in Finland was conducted independently by the Department of Exercise and Medical Physiology at Verve Research in the fall 2011.

Valkee launched its bright-light headset in August 2010. Being based on cross-functional science in neurology, biology, psychiatry and physiology, Valkee is a CE-certified Class II(a) medical device under the EU regulations.


About Valkee

The Valkee (http://valkee.com) bright light headset channels bright light direct to light-sensitive areas of the human brain via ear canals to improve mood and performance. In earlier clinical trials, 9 of 10 patients suffering from severe seasonal affective disorder - also known as winter blues - experienced total symptom relief latest in 4 weeks with a daily 8-12 minute dose. Valkee is based on scientific research carried out since 2007, and is a CE-marked Class II(a) medical device. More information and for international online shop http://valkee.com

About Department of Exercise and Medical Physiology at Verve

Verve is a Finnish nationwide provider of research, rehabilitation and consulting services for occupational health, and physiology and exercise research. The Department of Exercise and Medical Physiology at verve engages in cross-disciplinary research, which most significantly integrates exercise physiology, cardiology and mathematics. Verve's research team is especially interested in the interrelationships of cardiac function, exercise, stress and cognitive performance.



'/>"/>
SOURCE Valkee
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waterproof Keyboard Now Has Brighter, More Efficient Backlighting
2. Pharmacyclics to Present at Bank of America Merrill Lynch Healthcare Conference and MDB Bright Lights Conference
3. Solta Medical Receives Provectus Innovation Award at MDB Capital Groups Bright Lights Intellectual Property Conference
4. An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
5. 2011 China-Africa Brightness Action Launched in Beijing
6. Sanare Launches BrightSky, a New Consumer Brand Serving People Living With Diabetes
7. Sanare and BrightSky Announce National Strategic Partnership with American Diabetes Association
8. NewCardio to Showcase Cardiac Diagnostic Technology at MDB Capitals Bright Lights Conference in New York City on May 10, 2011
9. Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011
10. BrightLife Direct Introduces 3 New Lymphedema Product Lines
11. Alexza to Present at the MDB Bright Lights Conference 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
Breaking Medicine Technology:
(Date:6/26/2016)... Creek, Michigan (PRWEB) , ... June 26, 2016 , ... ... joined as sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in ... in honor of the city’s history as home to some of the world’s leading ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
Breaking Medicine News(10 mins):